Converging Pathways in Autism Spectrum Disorders: Interplay between Synaptic Dysfunction and Immune Responses

Autism spectrum disorders (ASD) are highly heritable, yet genetically heterogeneous neurodevelopmental conditions. Recent genome-wide association and gene expression studies have provided evidence supporting the notion that the large number of genetic variants associated with ASD converge toward a core set of dysregulated biological processes. Here we review recent data demonstrating the involvement of synaptic dysfunction and abnormal immune responses in ASD, and discuss the functional interplay between the two phenomena.

[1]  T. Bourgeron,et al.  Progress toward treatments for synaptic defects in autism , 2013, Nature Medicine.

[2]  M. State,et al.  Recent developments in the genetics of autism spectrum disorders. , 2013, Current opinion in genetics & development.

[3]  Andreas M. Grabrucker,et al.  Environmental Factors in Autism , 2013, Front. Psychiatry.

[4]  Michael E. Greenberg,et al.  Activity-dependent neuronal signalling and autism spectrum disorder , 2013, Nature.

[5]  Ben A. Barres,et al.  Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner , 2012, Neuron.

[6]  J. Sutcliffe,et al.  Loci nominally associated with autism from genome-wide analysis show enrichment of brain expression quantitative trait loci but not lymphoblastoid cell line expression quantitative trait loci , 2012, Molecular Autism.

[7]  Kenny Q. Ye,et al.  De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.

[8]  Michael F. Walker,et al.  De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.

[9]  Evan T. Geller,et al.  Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.

[10]  P. Ashwood,et al.  The role of immune dysfunction in the pathophysiology of autism , 2012, Brain, Behavior, and Immunity.

[11]  M. Bear,et al.  Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. , 2012, Cold Spring Harbor perspectives in biology.

[12]  Bradley P. Coe,et al.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.

[13]  A. Persico,et al.  Genome-wide expression studies in Autism spectrum disorder, Rett syndrome, and Down syndrome , 2012, Neurobiology of Disease.

[14]  James C. Cronk,et al.  Wild type microglia arrest pathology in a mouse model of Rett syndrome , 2012, Nature.

[15]  Pat Levitt,et al.  The conundrums of understanding genetic risks for autism spectrum disorders , 2011, Nature Neuroscience.

[16]  M. Giustetto,et al.  Synaptic Pruning by Microglia Is Necessary for Normal Brain Development , 2011, Science.

[17]  J. Raber,et al.  A role for glia in the progression of Rett’s syndrome , 2011, Nature.

[18]  Enrico Cherubini,et al.  Alterations of GABAergic Signaling in Autism Spectrum Disorders , 2011, Neural plasticity.

[19]  Gavin J. Wright,et al.  Neurexins, Neuroligins and LRRTMs: synaptic adhesion getting fishy , 2011, Journal of neurochemistry.

[20]  S. Horvath,et al.  Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology , 2011, Nature.

[21]  P. Patterson,et al.  Activation of the maternal immune system induces endocrine changes in the placenta via IL-6 , 2011, Brain, Behavior, and Immunity.

[22]  E. Courchesne,et al.  Microglial Activation and Increased Microglial Density Observed in the Dorsolateral Prefrontal Cortex in Autism , 2010, Biological Psychiatry.

[23]  Petr Tvrdik,et al.  Hematopoietic Origin of Pathological Grooming in Hoxb8 Mutant Mice , 2010, Cell.

[24]  P. Patterson.  Immune involvement in schizophrenia and autism: Etiology, pathology and animal models , 2009, Behavioural Brain Research.

[25]  Takeshi Sakurai,et al.  The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders , 2009, Trends in Neurosciences.

[26]  N. Lee,et al.  Gene Expression Profiling of Lymphoblasts from Autistic and Nonaffected Sib Pairs: Altered Pathways in Neuronal Development and Steroid Biosynthesis , 2009, PloS one.

[27]  Robert T. Schultz,et al.  Common genetic variants on 5p14.1 associate with autism spectrum disorders , 2009, Nature.

[28]  D. Harvey,et al.  Rett Syndrome Astrocytes Are Abnormal and Spread MeCP2 Deficiency through Gap Junctions , 2009, The Journal of Neuroscience.

[29]  G. Mandel,et al.  Non–cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology , 2009, Nature Neuroscience.

[30]  J. Gregg,et al.  Altered gene expression and function of peripheral blood natural killer cells in children with autism , 2009, Brain, Behavior, and Immunity.

[31]  D. Geschwind,et al.  Advances in autism genetics: on the threshold of a new neurobiology , 2008, Nature Reviews Genetics.

[32]  Huda Y. Zoghbi,et al.  The Story of Rett Syndrome: From Clinic to Neurobiology , 2007, Neuron.

[33]  Bryan Frank,et al.  Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes , 2006, BMC Genomics.

[34]  E. Cacci,et al.  Microglia‐derived tumor necrosis factor‐α exaggerates death of newborn hippocampal progenitor cells in vitro , 2005, Journal of neuroscience research.

[35]  L. Sommer,et al.  Wnt signaling: multiple functions in neural development , 2005, Cellular and Molecular Life Sciences CMLS.

[36]  A. Zimmerman,et al.  Neuroglial activation and neuroinflammation in the brain of patients with autism , 2005, Annals of neurology.

[37]  Detlef Balschun,et al.  A neuromodulatory role of interleukin-1β in the hippocampus , 1998 .

[38]  So Hyun Kim,et al.  The Behavioral Manifestations of Autism Spectrum Disorders , 2013 .

[39]  Yasuomi Ouchi,et al.  Microglial activation in young adults with autism spectrum disorder. , 2013, JAMA psychiatry.

[40]  M. Carson,et al.  An Introduction to CNS-Resident Microglia: Definitions, Assays, and Functional Roles in Health and Disease , 2013 .

[41]  J. Gregg,et al.  Gene expression changes in children with autism. , 2008, Genomics.

[42]  R. Malenka,et al.  Synaptic scaling mediated by glial TNF-alpha. , 2006, Nature.

[43]  F. Pitossi,et al.  A neuromodulatory role of interleukin-1beta in the hippocampus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Michael F. Lin,et al.  Disruption of a Large Intergenic Noncoding Rna in Subjects with Neurodevelopmental Disabilities Accessed Terms of Use Detailed Terms , 2022 .

[45]  S. Haggarty,et al.  Disruption of a Large Intergenic Noncoding Rna in Subjects with Neurodevelopmental Disabilities , 2022 .